Furthermore, analysis of FOXP1 expressions across cancer types from the GEPIA2 and Human Protein Atlas datasets showed that FOXP1 was overexpressed in multiple cancer types, with PAAD displaying the most pronounced upregulation (Fig. S1C). This evidence concerns the gene FOXP1 and cancer.